Central nervous system pharmacology of the dietary methylxanthines.
D000109:Acetylcholine / Q000378:metabolism; D000293:Adolescent; D000328:Adult; D000368:Aged; D001835:Body Weight; D002110:Caffeine / Q000032:analysis / Q000494:pharmacology*; D002490:Central Nervous System / Q000187:drug effects*; D004032:Diet; D004298:Dopamine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005247:Feeding Behavior; D005260:Female; D006801:Humans; D007928:Lethal Dose 50; D008297:Male; D008875:Middle Aged; D009043:Motor Activity / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000378:metabolism; D011963:Receptors, GABA-A / Q000378:metabolism; D011983:Receptors, Purinergic; D012701:Serotonin / Q000378:metabolism; D012890:Sleep / Q000187:drug effects; D019966:Substance-Related Disorders; D013805:Theobromine / Q000494:pharmacology*; D013806:Theophylline / Q000494:pharmacology*
D011956:Receptors, Cell Surface; D011963:Receptors, GABA-A; D011983:Receptors, Purinergic; D012701:Serotonin; D002110:Caffeine; D013806:Theophylline; D000109:Acetylcholine; D013805:Theobromine; D004298:Dopamine; D009638:Norepinephrine